查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1479836

多不饱和脂肪酸市场－2024年至2029年预测

Polyunsaturated Fatty Acids Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 143 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

多不饱和脂肪酸市场预计将以 8.13% 的复合年增长率成长，市场估值将从 2022 年的 107.17 亿美元增至 2029 年的 185.27 亿美元。

多效价脂肪是膳食脂肪的一种，与单元不饱和脂肪一起被归类为有益脂肪。这种类型的脂肪存在于植物和动物来源中，例如鲑鱼、植物油以及精选的坚果和种子。摄取适量的多不饱和脂肪酸（以及单元不饱和脂肪酸）而不是饱和脂肪酸和反式脂肪酸有助于整体健康。

多不饱和脂肪酸包括称为Omega-3和Omega-6脂肪酸的必需脂肪酸。 Omega-3和Omega-6脂肪酸在支持大脑功能和细胞生长方面发挥着重要作用。人体不能产生必需脂肪酸，因此必须从食品中获取它们。多不饱和脂肪酸的工业包括食品、营养补充、药品和饲料。

多不饱和脂肪酸分为Omega-3和omega-6脂肪酸。这种差异反映了这些脂肪酸在促进健康方面所发挥的不同作用。此外，多不饱和脂肪酸市场按形式细分，为消费者提供多样化的选择。有锭剂、液体、软胶囊和粉末可供选择，每种都能满足各种偏好且易于食用。多不饱和脂肪酸的这种多效性因其营养价值和在各行业的多样化应用而变得有用。

市场驱动因素

  • 老年人口意识不断增强

多不饱和脂肪酸(PUFA) 对于维持最佳健康至关重要，尤其是老年族群。在PUFA中， Omega-3脂肪酸如DHA在维持大脑健康方面发挥重要作用。研究表明，这些脂肪酸可能有助于维持认知功能、降低失智症风险并改善老年人的记忆力。

此外，PUFA，特别是Omega-3脂肪酸，具有发炎特性，有助于管理各种健康状况，并有助于整体健康。人口老化趋势明显，统计数据显示，老年人口数量显着增加。到 2020 年，美国大约有六分之一的人年龄在 65 岁以上，这与 1920 年的人口结构形成鲜明对比，当时这个年龄层的人口比例不到二十分之一。

这种全球老化现像在日本等国家也很明显，日本是世界上人口老化程度最高的国家。目前，日本超过十分之一的人年龄超过80岁，处于老化浪潮的最前线。

不断变化的年龄特征强调需要解决与老龄化相关的健康问题的解决方案，从而导致对多元不饱和脂肪酸等补充品的需求增加。

  • 慢性病增加

心血管疾病、糖尿病和神经退化性疾病等慢性疾病的全球盛行率正在稳步上升，需要营养补充食品控制这些症状并改善整体健康。 CDC 报告称，美国十分之六的成年人至少患有一种慢性病，十分之四的人患有两种或两种以上慢性病。 2021年，美国糖尿病协会透露，有3,840万美国人被诊断出患有糖尿病，占总人口的11.6%。同样，世界卫生组织（WHO）指出，在印度，18岁以上的人有7,700万患有第2型糖尿病。这些令人震惊的数字凸显了迫切需要采取干预措施来促进健康和对抗慢性病的传播。

为了应对这一日益严重的健康危机，对富含健康促进成分的机能性食品、食品和饮料的需求正在迅速增加。多元不饱和脂肪酸正在成为这一趋势的关键参与者，并应用于多种产品，包括强化乳类饮料、涂抹酱、烘焙点心和婴儿奶粉。

市场限制因素

  • 价格波动

多不饱和脂肪酸来自海洋来源，例如鱼油和精选农产品，并且会根据气候条件和供应链内的其他不确定因素而受到价格波动的影响。这些波动给生产和购买 PUFA 的製造商和消费者都带来了挑战。由于 PUFA 对外部因素很敏感，因此行业内需要采取适应策略，以使製造商和消费者都能以实惠的价格获得 PUFA。

多不饱和脂肪酸市场按类型细分： Omega-3和 Omega-6。

在PUFA市场中，按类型细分主要包括两大类： Omega-3和Omega-6。 Omega-3脂肪酸已被证明可以透过有效降低坏胆固醇 (LDL) 同时提高好胆固醇 (HDL) 来降低心臟病和中风的风险。因此，对富含Omega-3 的机能性食品和饮料的需求不断增加。另一方面，Omega-6 存在于更广泛的食品来源中，因此更容易融入您的日常饮食中。 Omega-6脂肪酸在各种食品中的多功能性使其易于整合。

预计北美将占据多不饱和脂肪酸市场的主要份额。

北美将在 PUFA 市场中占据显着地位，有几个影响因素促成了这一点。一个重要因素是大众对多元不饱和脂肪酸的健康益处的认识不断提高。这种日益增长的意识正在推动对富含 PUFA 的食品、饮料和补充品的强劲需求。

北美在 PUFA 市场占据主导地位的一个主要因素是其强劲的经济，其特点是与许多其他地区相比可支配收入较高。世界银行报告显示，截至2021年，美国最终消费支出为19.26兆美元。这种经济力量使消费者能够将更多资源分配到含有多元不饱和脂肪酸的健康和保健产品。意识的提高和强劲的经济状况相结合，凸显了北美在塑造 PUFA 市场方面的重要作用。

公司产品

  • Ultra Omega-3 /6/9(TM) 软胶囊 - NaturesPlus 提供 Ultra Omega-3 /6/9(TM) 软胶囊，这是一种食品配製的营养补充，可提供必需不饱和脂肪酸的最佳比例。此补充品由最优质的非基因改造成分製成，包括琉璃苣油、鱼油和助焊剂，可促进心臟健康，保持骨骼强健，滋养皮肤活力，支持认知功能，旨在支持您的整体健康。
  • MARNYS(R) Omega-MARNYS(R) Omega 3+6 Junior 是一种有价值的食品补充品，它利用了从琉璃苣和助焊剂中提取的必需植物性欧米茄油的功效。琉璃苣提供的 omega-6 脂肪酸含量超过 20%，亚麻籽提供的Omega-3含量超过 55% α-亚麻酸。这种独特的组合可支持正常的心血管和胃肠功能，并在维持健康的免疫系统方面发挥重要作用。
  • Momentous 推出 Omega-3-Momentous 提供富含必需脂肪酸的Omega-3补充品，尤其是从鱼油中提取的 EPA 和 DHA。我们建议每天随餐服用两粒软胶囊。将这种补充品纳入您的日常生活可以有助于实现您的营养目标。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表

第二章调查方法

  • 调查资料
  • 调查过程

第三章执行摘要

  • 研究亮点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析

第五章多不饱和脂肪酸市场：依应用

  • 介绍
  • 食品
  • 营养补充食品
  • 製药
  • 餵食

第六章多不饱和脂肪酸市场：依类型

  • 介绍
  • Omega-3
  • 欧米伽6

第七章多不饱和脂肪酸市场：依形式

  • 介绍
  • 锭剂
  • 液体
  • 软凝胶
  • 粉末

第八章多不饱和脂肪酸市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 其他的
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作

第十章 公司简介

  • Healthyr U
  • Matreya LLC
  • Merck KGaA, Darmstadt
  • RawRX
  • Kemin Industries, Inc.
  • Mad Barn Inc.
  • Carlson Labs
  • Momentous
  • Marnys
  • Nature's Plus
简介目录
Product Code: KSI061616421

The polyunsaturated fatty acids market is projected to rise at a compound annual growth rate (CAGR) of 8.13% to reach a market valuation of US$18.527 billion by 2029, from US$10.717 billion in 2022.

Polyunsaturated fat, a variant of dietary fat, is classified among the beneficial fats alongside monounsaturated fat. This type of fat is present in both plant and animal sources, including salmon, vegetable oils, and select nuts and seeds. Moderate consumption of polyunsaturated (as well as monounsaturated) fats instead of saturated and trans fats can contribute to overall health.

Polyunsaturated fats include essential fatty acids known as omega-3 and omega-6 fats. These play a crucial role in supporting brain function and cell growth. Since our bodies do not produce essential fatty acids, obtaining them from food sources is imperative. The industry applications of polyunsaturated fatty acids include food, nutraceuticals, pharmaceuticals, and feed applications.

Polyunsaturated fatty acids are categorized by type, with distinctions made between Omega-3 and Omega-6. This differentiation reflects the diverse roles these fatty acids play in promoting health. Furthermore, the polyunsaturated fatty acids market is segmented by form, offering diverse options for consumers. These include tablets, liquids, soft gels, and powders, each catering to varied preferences and ease of consumption. This multifaceted nature of polyunsaturated fats makes them useful for their nutritional significance and their diverse applications in different industries.

Market Drivers

  • Rising awareness in the geriatric population

Polyunsaturated fatty acids (PUFAs) are crucial for maintaining optimal health, particularly in the geriatric population. Among PUFAs, omega-3s, such as DHA, play a vital role in supporting brain health. Research suggests that these fatty acids contribute to preserving cognitive function, lowering the risk of dementia, and potentially improving memory in older adults.

Furthermore, PUFAs, especially omega-3s, exhibit anti-inflammatory properties that can help manage various health conditions and contribute to overall well-being. The demographic shift towards an aging population is evident, with statistics indicating a notable increase in the elderly population. In 2020, approximately 1 in 6 individuals in the United States were aged 65 and above, in stark contrast to the demographic composition in 1920, where this age group comprised less than 1 in 20 of the population.

This global aging phenomenon in countries like Japan is known for having the world's oldest population. In Japan, more than 1 in 10 individuals are now aged 80 or older, placing the country at the forefront of the ageing demographic wave.

The evolving age structure underscores the need for solutions that address health concerns associated with aging, leading to an increased demand for supplements such as PUFAs.

  • Rising prevalence of chronic diseases

The global incidence of chronic diseases, including cardiovascular ailments, diabetes, and neurodegenerative disorders, is steadily increasing, demanding dietary supplements to manage these conditions and enhance overall health outcomes. Statistics highlight the severity of this health challenge, with 6 out of 10 adults in the United States affected by at least one chronic disease, and 4 out of 10 having two or more, as reported by the CDC. In 2021, the American Diabetes Association revealed that 38.4 million Americans, constituting 11.6% of the population, were diagnosed with diabetes. Similarly, the World Health Organization notes that in India, a staggering 77 million individuals above the age of 18 are grappling with type 2 diabetes. These alarming figures underscore the urgent need for interventions that promote health and combat the rising prevalence of chronic diseases.

In response to this growing health crisis, there is a surging demand for functional foods and beverages enriched with health-promoting ingredients. PUFAs are emerging as a key player in this trend, finding applications in various products such as fortified dairy drinks, spreads, baked goods, and infant formula.

Market Restraints

  • Price volatility

Polyunsaturated fatty acids, derived from marine sources such as fish oil and select agricultural sources, are susceptible to price fluctuations influenced by climate conditions and other uncertainties within the supply chain. These variations pose challenges for both manufacturers and consumers in producing and purchasing PUFAs. The sensitivity of PUFAs to external factors underscores the need for adaptive strategies within the industry to make them affordable for both manufacturers and consumers.

The polyunsaturated fatty acids market is segmented by type, with omega-3 and omega-6.

Within the PUFA market, segmentation by type primarily comprises two main categories: omega-3 and omega-6. Omega-3 fatty acids are recognized for their potential to reduce the risk of heart disease and stroke by effectively lowering bad cholesterol (LDL) while simultaneously elevating good cholesterol (HDL). This has fueled a growing demand for functional foods and beverages enriched with omega-3s. On the other hand, omega-6 is found in a broader spectrum of food sources, rendering them more accessible for incorporation into the daily diet. The versatility of omega-6 fatty acids in various foods enhances their ease of integration.

North America is anticipated to hold a significant share of the polyunsaturated fatty acids market.

North America will hold a notable position in the PUFA market, by several influential factors contribute to this position. One key factor is the heightened general awareness of the health benefits associated with PUFAs. This increased awareness acts as a driving force, generating a robust demand for PUFA-enriched foods, beverages, and supplements within the region.

A significant contributor to North America's dominance in the PUFA market is its robust economy, characterized by higher disposable incomes compared to many other regions. As of 2021, the United States recorded a final consumption expenditure of 19.26 trillion current US dollars, as reported by the World Bank. This economic strength empowers consumers to allocate more resources toward health and wellness products, including those containing PUFAs. The combination of heightened awareness and a strong economic landscape underscores North America's important role in shaping the PUFA market.

Market developments

  • October 2023 - Dsm-Firmenich announced the launch of life's(R)omega o3020, marking a milestone as the first and only single-source algal omega-3 with an EPA/DHA ratio identical to that naturally found in fish oil. Life's(R)omega o3020 presented a notable ratio of 1.5:1 EPA (eicosapentaenoic acid) to DHA (docosahexaenoic acid); this is twice the potency. The launch represented a significant advancement in providing consumers with a potent and sustainable algal omega-3 option, aligning with evolving preferences and industry trends.
  • April 2023 - The leading biotech company, Mialgae, successfully launched its omega-3 product, Naturalgae, to the market following the recent expansion of its commercial production site in Scotland. Mialgae pioneered a sustainable approach by recycling co-products from the scotch whisky industry, such as pot ale, to cultivate omega-3-rich microalgae. These microalgae serve as an excellent source for producing nutritious fish feed and pet food ingredients.
  • March 2022 - Polaris, a prominent leader in fatty acids characterized by high concentrations of EPA and DHA, announced a successful fundraising round of €5 million, spearheaded by Seventure partners through its Health for Life capital(TM) fund. This infusion of capital has positioned the company, which previously operated in Japan, South Korea, and recently the United States, to fortify its international expansion efforts. Additionally, the financial injection will facilitate the expansion of Polaris' sustainable production unit located in Brittany, France.

Company Products

  • Ultra Omega 3/6/9(TM) Softgels - NaturesPlus offers Ultra Omega 3/6/9(TM) Softgels, a dietary supplement meticulously formulated to provide optimal ratios of essential unsaturated fatty acids. Crafted from top-quality non-GMO sources, including borage oil, fish oil, and flax oil, this supplement is designed to support overall well-being by promoting heart health, maintaining strong bones, nurturing skin vitality, and supporting cognitive function.
  • MARNYS(R) Omega - MARNYS(R) Omega 3+6 Junior is a valuable food supplement harnessing the power of essential vegetable omega oils derived from borage and flaxseed. Borage contributes Omega-6, featuring a minimum gamma-linoleic acid (GLA) content of 20%, while Flaxseed provides Omega-3, with a minimum a-linolenic acid content of 55%. This unique combination plays a crucial role in supporting normal cardiovascular and gastrointestinal functions, as well as contributing to the maintenance of a healthy immune system. The supplement is particularly beneficial during periods of growth and organ maturation in children.
  • Momentous presents Omega-3 - Momentous offers its Omega-3 supplement, a formulation rich in essential fatty acids sourced from fish oil, specifically EPA and DHA. It is recommended to take 2 soft gels with food daily. Incorporating this supplement as part of your daily routine can contribute to nutritional goals.

Market Segmentation

By Application

  • Food
  • Nutraceutical
  • Pharmaceutical
  • Feed Applications

By Type

  • Omega-3
  • Omega-6

By Form

  • Tablet
  • Liquid
  • Softgel
  • Powder

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. POLYUNSATURATED FATTY ACIDS MARKET BY APPLICATION

  • 5.1. Introduction
  • 5.2. Food
  • 5.3. Nutraceutical
  • 5.4. Pharmaceutical
  • 5.5. Feed Applications

6. POLYUNSATURATED FATTY ACIDS MARKET BY TYPE

  • 6.1. Introduction
  • 6.2. Omega-3
  • 6.3. Omega-6

7. POLYUNSATURATED FATTY ACIDS MARKET BY FORM

  • 7.1. Introduction
  • 7.2. Tablet
  • 7.3. Liquid
  • 7.4. Softgel
  • 7.5. Powder

8. POLYUNSATURATED FATTY ACIDS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. The Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations

10. COMPANY PROFILES

  • 10.1. Healthyr U
  • 10.2. Matreya LLC
  • 10.3. Merck KGaA, Darmstadt
  • 10.4. RawRX
  • 10.5. Kemin Industries, Inc.
  • 10.6. Mad Barn Inc.
  • 10.7. Carlson Labs
  • 10.8. Momentous
  • 10.9. Marnys
  • 10.10. Nature's Plus